Bayer Healthcare Pharmaceuticals (Bayer) have announced the second round of the Bayer Ophthalmology Awards Program (BOAP). They are calling for submissions from Australian ophthalmologists and researchers in the field of retinal ophthalmology. The awards aim to advance the scientific understanding and clinical management of retinal ophthalmic disorders.
A total of six grants, each worth up to US$50,000, supporting research and training in retinal ophthalmology, will be awarded to successful applicants from across the world. The grants include three Fellowship Project Awards, intended to facilitate the development of research and clinical expertise in the field of retinal ophthalmology and three Research Awards, which aim to support a wide range of clinical and/or basic research projects in retinal ophthalmology.
As part of the company's commitment to eye health in an effort to further research and development in ophthalmology, Rene Klemm, Bayer Healthcare General Manager Australia, encourages Australians working in ophthalmology to apply for the GOAP.
"The efforts of Australian ophthalmologists in working to better understand, manage and ultimately treat eye disease, are internationally renowned.
"We challenge those working in the field to put their innovative work in the spotlight, apply, and show the world what they can do," said Rene Klemm.
A letter of intent for the 2013 awards must be submitted on or before 30 April, 2013.
To read the full press release, please click here.
For further information please visit www.bayer-ophthalmology-awards.com
17 January 2013